Leap therapeutics reports first quarter 2021 financial results

Cambridge, mass., may 14, 2021 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the first quarter ended march 31, 2021.
LPTX Ratings Summary
LPTX Quant Ranking